The online symposium on “Advances in Proteomics and Metabolomics 2021” highlights the latest advances in proteomics and metabolomics research and their applications in modern medicine. This event from Technology Networks featured a collection of exclusive talks from leading scientists in the field, discussing their research and lending insights on the advances and challenges in this exciting space.
The insights offered by proteomic and metabolomic approaches are helping to shape our understanding of diseases, accelerate the development of novel clinical biomarkers and facilitate drug discovery. If you want to learn how proteomics and metabolomics insights are fundamental in our pursuit towards personalized medicine, and how Bruker is contributing to this check out our on-demand presentations from this event.
Gary Kruppa, Ph.D., Vice President Proteomics at Bruker Daltonics Inc., and Managing Director of Bruker S.R.O., Billerica, MA, USA
Jeffrey Spraggins, Ph.D.,
Research Assistant Professor, Department of Biochemistry, Vanderbilt University, Nashville, TN, USA
For Research Use Only. Not for use in clinical diagnostic procedures.